Institutional investors purchased a net $1.0 million shares of SGEN during the quarter ended December 2016 and now own 98.09% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APO ASSET MANAGEMENT GMBH Bought 53.0 Thousand shares of Seattle Genetics Inc
CAPITAL IMPACT ADVISORS LLC Bought 32.3 Thousand shares of Seattle Genetics Inc
CANDRIAM LUXEMBOURG SA Bought 27.0 Thousand shares of Seattle Genetics Inc